China
Africa
Explore chapters and articles related to this topic
Community Engagement and Women's Health
Published in Michelle Tollefson, Nancy Eriksen, Neha Pathak, Improving Women's Health Across the Lifespan, 2021
Cheryl True, Elisabeth Fontaine, Erin Phillips
CBIs can move research to action. A primary example is a Community-Engaged Lifestyle Medicine (CELM) framework, shown to improve health outcomes and address health disparities.7 The US Department of Health and Human Services Office on Women’s Health (OWH) developed a community-based initiative entitled Coalition for a Healthier Community (CHC).8 The goals of the CHC are to address gender-based health inequities and support community-wide health of women and girls. The Coalition for a Healthier Community for Utah Women and Girls (CHC-UWAG) used a gender-based approach to address obesity rates in women and girls. The CBIs used wellness coaching for healthy eating and physical activity and led to policy initiatives to improve the health of women and girls.9
Healthcare Policy in the United States
Published in Kant Patel, Mark Rushefsky, Healthcare Politics and Policy in America, 2019
Within the HHS, under the Assistant Secretary of Health, a number of public health offices perform a variety of public health activities. For example, the National Vaccine Program Office (NVPO) coordinates vaccine and immunization activities of different federal agencies. The Office of Minority Health (OMH) deals with issues related to health status and quality of life for the minority population, while the Office on Women’s Health (OWH) promotes improvement in women’s health. For a comprehensive list of public health offices and their activities, visit www.hhs.gov/ash/public-health-offices/index.html.
Women’s Health and Nutrition
Published in Mary J. Marian, Gerard E. Mullin, Integrating Nutrition Into Practice, 2017
In 1990, the Office of Research on Women’s Health (ORWH), established within the National Institutes of Health (NIH), was the first public health office dedicated specifically to women’s health [2]. In 1991, the Office on Women’s Health (OWH) was established within the U.S. Department of Health and Human Services (HHS) to be followed in 1994 with the establishment of the Office of Women’s Health (OWH) within the Food and Drug Administration (FDA) [3,4]. While the mission of each of these offices may slightly differ, they all are committed to addressing women’s health.
Risk Language and Infant Feeding Behaviors: A Longitudinal Analysis
Published in Women's Reproductive Health, 2021
Lora Ebert Wallace, Erin N. Taylor
Advocacy to stop describing breastfeeding as “best” or “superior” and instead to use words such as “risky” to describe formula has slowly made progress within the breastfeeding promotion communities and professions (Slaw, 1999; Wiessinger, 1996). Beyond discussion of advocacy for the use of “risk” language in breastfeeding promotion in the academic and professional literatures (Kelleher, 2006; Kukla, 2006; McNiel et al., 2010; Slaw, 1999; Smith et al., 2009; Wiessinger, 1996; Wolf, 2007; see also Stuebe, 2009, for a relevant publication intended for physicians), “risk” language has been adopted by health care organizations in the United States. A cursory review of US state health department websites yielded examples of the use of “risk” language in the publications posted (e.g., Kansas WIC, 2008). Many of these publications draw from the 2011 US Surgeon General’s “Call to Action” (Office of the Surgeon General (U.S.); Centers for Disease Control and Prevention (U.S.); Office on Women’s Health (U.S.), 2011) and the 2012 statement from the American Academy of Pediatrics entitled “Breastfeeding and the Use of Human Milk” (American Academy of Pediatrics, 2012). A page from the California Department of Public Health’s website entitled “California Infant Feeding Guide” (Haydu & Gamba, 2006) is also based on the 2011 Surgeon General’s Report.
A Gendered Account of Alcoholics Anonymous’ “Singleness of Purpose”
Published in Alcoholism Treatment Quarterly, 2019
What is not overtly discussed is the role of the pharmaceutical industry and its rise since the turn of the century. However, it is clear that the medical profession dominated by men through the 1990s saw female patients in a certain light and the question of abusing opioids is rarely raised. Not until celebrities and other high-profile women such as Kitty Dukakis (wife of the democratic presidential nominee in 1988) make public the problem of pill addiction does the issue receive attention. Public awareness has spiked for short periods of time when pop stars such as Whitney Houston and others have succumbed to opioid addiction and death. The concern over opioid abuse has fallen on silent ears as the problem has been associated with women and in the worse instance neurotic women. Today, the spot light is on the pharmaceutical industry and the concern has grown as the connections are being made between legally prescribed medications and the pathway to illegal use of street drugs. At the same time, however, advertisements and targeted consumption of medications has grown and is a billion-dollar industry. Given that women are already more at risk to experience chronic and acute pain compared to their male counterpart that leads to a prescription opioids, there is some consumer vulnerability. Moreover, women are also more at risk to develop dependence due to telescoping and other biological factors (Office on Women’s Health, 2016) that needs to be considered when prescribing opioids
A gendered account of Alcoholics Anonymous (AA’s) “Singleness of Purpose”
Published in Alcoholism Treatment Quarterly, 2018
What is not overtly discussed is the role of the pharmaceutical industry and its rise since the turn of the century. However, it is clear that the medical profession dominated by men through the 1990s saw female patients in a certain light and the question of abusing opioids is rarely raised. Not until celebrities and other high-profile women such as Kitty Dukakis (wife of the democratic presidential nominee in 1988) make public the problem of pill addiction does the issue receive attention. Public awareness has spiked for short periods of time when pop stars such as Whitney Houston and others have succumbed to opioid addiction and death. The concern over opioid abuse has fallen on silent ears as the problem has been associated with women and in the worse instance neurotic women. Today, the spotlight is on the pharmaceutical industry, and the concern has grown as the connections are being made between legally prescribed medications and the pathway to illegal use of street drugs. At the same time, however, advertisements and targeted consumption of medications has grown and is a billion-dollar industry. Given that women are already more at risk to experience chronic and acute pain compared to their male counterpart that leads to a prescription opioids, there is some consumer vulnerability. Moreover, women are also more at risk to develop dependence due to telescoping and other biological factors (Office on Women’s Health, 2016) that needs to be considered when prescribing opioids